IL2 and neoplasm: However, when CR and CAR are co-expressed on T cells, the therapeutic effect of T cells can be significantly improved by IL-2 and IFN-γ secretion, suggesting that CR-T cells may reduce the resistance of tumor cells during the treatment process to help CR and CAR prolong the timing of CA125 interaction.